Menu
29/05/2012
Boots Ireland Lowers Cost Of Prescription Medicines
Boots Ireland has today announced new lower prescription medicine prices that will lead to significant savings for Irish customers.
The changes will dramatically reduce the price of the majority of prescription medicines. Across the top-ten most expensive prescription medicines, all medicines will reduce in price, with an average saving of 25%.
The new prices will come into effect from Friday 1 June 2012.
Annual medicine bills for people living with chronic conditions such as asthma or cardiovascular disease who are not eligible for the GMS Medical Card scheme will benefit most. A person living with asthma has a typical monthly medicine bill of €94.65. This will now drop to approximately €70.43 (26% decrease), representing an annual saving of up to €290.64. A typical person living with a cardiovascular condition such as high blood pressure and high cholesterol may see their medicine bill drop from €77.88 to €65.92 (15% decrease), representing an annual saving of up to €203.88.
Speaking about the announcement, Mary Rose Burke, Director of Pharmacy, Boots Ireland said: "In recent years, many of our customers have come under renewed financial pressures. In response to this, Boots Ireland is the first pharmacy retailer in Ireland to announce a commitment to delivering a clear and transparent pricing structure that will also result in significant savings for Boots Ireland customers. Our new structure reflects the important role that Boots Ireland pharmacists play in the provision of professional care in the communities they serve in our 65 pharmacy outlets nationwide. Boots Ireland aims to be the leading healthcare partner in the community and is striving to achieve this by providing accessible healthcare solutions underpinned by the best value and care to customers. Boots mission is to provide dynamic and innovative healthcare services and solutions that deliver active care to customers around the country helping them to feel good in their everyday life."
(CD/GK)
The changes will dramatically reduce the price of the majority of prescription medicines. Across the top-ten most expensive prescription medicines, all medicines will reduce in price, with an average saving of 25%.
The new prices will come into effect from Friday 1 June 2012.
Annual medicine bills for people living with chronic conditions such as asthma or cardiovascular disease who are not eligible for the GMS Medical Card scheme will benefit most. A person living with asthma has a typical monthly medicine bill of €94.65. This will now drop to approximately €70.43 (26% decrease), representing an annual saving of up to €290.64. A typical person living with a cardiovascular condition such as high blood pressure and high cholesterol may see their medicine bill drop from €77.88 to €65.92 (15% decrease), representing an annual saving of up to €203.88.
Speaking about the announcement, Mary Rose Burke, Director of Pharmacy, Boots Ireland said: "In recent years, many of our customers have come under renewed financial pressures. In response to this, Boots Ireland is the first pharmacy retailer in Ireland to announce a commitment to delivering a clear and transparent pricing structure that will also result in significant savings for Boots Ireland customers. Our new structure reflects the important role that Boots Ireland pharmacists play in the provision of professional care in the communities they serve in our 65 pharmacy outlets nationwide. Boots Ireland aims to be the leading healthcare partner in the community and is striving to achieve this by providing accessible healthcare solutions underpinned by the best value and care to customers. Boots mission is to provide dynamic and innovative healthcare services and solutions that deliver active care to customers around the country helping them to feel good in their everyday life."
(CD/GK)
Related Irish News Stories
Click here for the latest headlines.
12 November 2013
Gardai Appeal After Poison Stolen From Co Kildare Vet
Gardaí and the Irish Medicines Board (IMB) have appealed for anyone with any information about a robbery at a veterinary clinic in Celbridge, Co Kildare, to contact them.
Gardai Appeal After Poison Stolen From Co Kildare Vet
Gardaí and the Irish Medicines Board (IMB) have appealed for anyone with any information about a robbery at a veterinary clinic in Celbridge, Co Kildare, to contact them.
21 August 2012
IMB Warns Against Use Of Echinacea For Children
Parents should not give children under 12 any herbal products containing Echinacea, according to the Irish Medicines Board. The agency said there is no science to supporting the use of such products, and that there is also a risk of rare but severe side effects.
IMB Warns Against Use Of Echinacea For Children
Parents should not give children under 12 any herbal products containing Echinacea, according to the Irish Medicines Board. The agency said there is no science to supporting the use of such products, and that there is also a risk of rare but severe side effects.
25 March 2013
Survey Finds Big Difference In Pharmacy Drug Prices
Some pharmacies are charging double the price of other pharmacies for some drugs, according to a survey conducted by the National Consumer Agency. The survey shows considerable differences in the cost of individual prescription medicines in local areas.
Survey Finds Big Difference In Pharmacy Drug Prices
Some pharmacies are charging double the price of other pharmacies for some drugs, according to a survey conducted by the National Consumer Agency. The survey shows considerable differences in the cost of individual prescription medicines in local areas.
20 July 2016
IPU Welcomes Announcement To Reduce Price Of Medicines
The Irish Pharmacy Union (IPU) has welcomed the agreement between IPHA and the Government to reduce the price of medicines. However, the IPU expressed concern at the short lead-in time, which will mean that pharmacists with existing stocks will be financially hit.
IPU Welcomes Announcement To Reduce Price Of Medicines
The Irish Pharmacy Union (IPU) has welcomed the agreement between IPHA and the Government to reduce the price of medicines. However, the IPU expressed concern at the short lead-in time, which will mean that pharmacists with existing stocks will be financially hit.
08 April 2015
IPU Warns Parents Not To Give Children Under 12 Codeine-Containing Medicines
The Irish Pharmacy Union (IPU) is warning parents not to treat children below 12 years old with codeine-containing medicines for coughs and colds because of the risk of serious side-effects. In addition, the use of codeine for coughs and colds is not recommended in adolescents between 12 and 18 years who already have problems with their breathing.
IPU Warns Parents Not To Give Children Under 12 Codeine-Containing Medicines
The Irish Pharmacy Union (IPU) is warning parents not to treat children below 12 years old with codeine-containing medicines for coughs and colds because of the risk of serious side-effects. In addition, the use of codeine for coughs and colds is not recommended in adolescents between 12 and 18 years who already have problems with their breathing.
-
Ireland WeatherThis Evening and Tonight:Any rain along the north coast soon clearing north to give a dry evening. Further rain will move south and east in the early hours, occasionally heavy. Remaining mild. Minimum temperature 8 °C.
